7 phenotypes from 7 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Igs2em5(CAG-Mir802)Gpt/Igs2em5(CAG-Mir802)Gpt Tg(Ins2-cre)25Mgn/0 involves: C57BL/6JGpt * DBA	abnormal pancreatic beta cell differentiation	J:287584
	decreased circulating insulin level	J:287584
	decreased insulin secretion	J:287584
	decreased pancreatic beta cell mass	J:287584
	decreased pancreatic beta cell number	J:287584
	impaired glucose tolerance	J:287584
Igs2tm1(ACTB-EGFP,-tdTomato)Luo/Igs2tm1(ACTB-EGFP,-tdTomato)Luo involves: 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:166047
Igs2tm1(ACTB-EGFP,-tdTomato)Luo/Igs2tm2(ACTB-tdTomato,-EGFP)Luo involves: 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:166047
Igs2tm1(ACTB-EGFP,-tdTomato)Zng/Igs2tm1(ACTB-EGFP,-tdTomato)Zng involves: 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:202665
Igs2tm1(CAG-cas9*)Mmw/Igs2tm1(CAG-cas9*)Mmw involves: 129S1/Sv * 129X1/SvJ * C57BL/6	no abnormal phenotype detected	J:101977
Igs2tm1(CAG-mt-Keima)Fink/Igs2tm1(CAG-mt-Keima)Fink either: FVBNCrl.129(Cg)-Igs2tm1(CAG-mt-Keima)Fink or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J * FVB/NCrl)	no abnormal phenotype detected	J:270139
Igs2tm2(ACTB-tdTomato,-EGFP)Luo/Igs2tm2(ACTB-tdTomato,-EGFP)Luo involves: 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:166047
Igs2tm2(ACTB-tdTomato,-EGFP)Zng/Igs2tm2(ACTB-tdTomato,-EGFP)Zng involves: 129S1/Sv * 129X1/SvJ	no abnormal phenotype detected	J:202665